Ken Griffin Armata Pharmaceuticals, Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 400 shares of ARMP stock, worth $780. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 100
300.0%
Holding current value
$780
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ARMP
# of Institutions
27Shares Held
1.38MCall Options Held
400Put Options Held
17.3K-
Bank Of America Corp Charlotte, NC634KShares$1.24 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA225KShares$439,3090.0% of portfolio
-
Geode Capital Management, LLC Boston, MA107KShares$208,7780.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$195,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX75.4KShares$146,9940.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $70.5M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...